Singapore, Singapore

See Voon Seow

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: National University of Singapore, Nkarta, Inc., Agency for Science and Research. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: See Voon Seow. Retrieved from https://idiyas.com/inventor/see-voon-seow

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 60.0

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of See Voon Seow: Pioneering Advances in Natural Killer Cell Therapy

Introduction: See Voon Seow is a notable inventor based in Singapore, recognized for his significant contributions to the field of immunotherapy through his research on Natural Killer (NK) cells. With a portfolio that includes five patents, his work focuses on enhancing the ability of immune cells to target and eliminate cancerous and infected cells, paving the way for innovative treatment options.

Latest Patents: Among his latest patents, See Voon Seow has developed compositions of immune cells featuring truncated NKG2D chimeric receptors. This invention involves engineered NK cells that possess a chimeric receptor, enabling them to effectively target specific cells, particularly those affected by diseases like cancer. The technology encompasses various embodiments, including NK cells that exhibit cytotoxic effects upon binding to target cells expressing natural ligands of NKG2D.

Another important patent relates to activating chimeric receptors and their applications in NK cell immunotherapy. This invention includes polynucleotides encoding engineered NKG2C receptors, which demonstrate an enhanced affinity for HLA class I histocompatibility antigen. The resulting NK cells displaying such constructs are capable of inducing significant cytotoxicity against cancer cells, showcasing promising therapeutic potential.

Career Highlights: See Voon Seow's career is marked by his association with prominent institutions, most notably the National University of Singapore. His academic and practical contributions in the field of innovative immunotherapy have earned him recognition and respect among his peers and the scientific community.

Collaborations: Throughout his career, See Voon has collaborated with distinguished colleagues, including Dario Campana and Kaw Yan Chua. Their collective expertise has played a crucial role in advancing research and development in the field of NK cell therapy.

Conclusion: See Voon Seow stands out as an influential inventor in the realm of immunotherapy, with patents that reflect his innovative spirit and commitment to enhancing medical treatment through advanced technologies. His work continues to inspire future research and development, aiming to improve patient outcomes in the fight against cancer and infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…